Page last updated: 2024-12-04

2-(n-heptyl)-4-hydroxyquinoline n-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(n-heptyl)-4-hydroxyquinoline N-oxide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-heptyl-4-hydroxyquinoline N-oxide : An inhibitor of the mitochondrial respiratory chain at cytochrome bc1 and of photosynthetic electron flow immediately before cytochrome b559. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1561
CHEMBL ID1233401
CHEMBL ID4764074
CHEBI ID28362
CHEBI ID157768
SCHEMBL ID429766
SCHEMBL ID21065453
MeSH IDM0041470

Synonyms (40)

Synonym
4-quinolinol, 2-heptyl-, 1-oxide
CHEMBL1233401
2-heptyl-4-quinolinol 1-oxide
hoqno
CHEBI:28362 ,
2-heptylquinolin-4-ol 1-oxide
2-(n-heptyl)-4-hydroxyquinoline n-oxide
2-heptyl-4-hydroxyquinoline n-oxide
2-heptyl-4-hydroxy quinoline n-oxide
341-88-8
hqno
C04284
2-heptyl-4-hydroxyquinoline-n-oxide
2-heptyl-1-oxy-quinolin-4-ol
2-n-heptyl-4-hydroxyquinoline-n-oxide
DB07918
2-heptyl-1-hydroxy-4(1h)-quinolinone
CHEBI:157768
2-heptyl-1-hydroxyquinolin-4-one
1fu5s5cg6a ,
hqno [mi]
S8970
2-heptyl-4-hydroxyquinoline-1-oxide
SCHEMBL429766
J-019483
1-hydroxy-2-heptyl-4-quinolone
2 heptyl 4 hydroxyquinoline 1 oxide
2-heptyl-4-hydroxyquinoline 1-oxide
Q27097153
mfcd00057295
SCHEMBL21065453
D81225
2-heptyl-4-hydroxyquinolin-1-ium-1-olate
2-heptyl-1-hydroxyquinolin-4(1h)-one
DTXSID20955644
AS-82836
2-heptyl-1-hydroxy-1,4-dihydroquinolin-4-one
CHEMBL4764074
Z1436474324
AKOS040759397
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monohydroxyquinolineA hydroxyquinoline carrying a single hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (14)

PathwayProteinsCompounds
nitrate reduction III (dissimilatory)1219
nitrate reduction VIII (dissimilatory)1915
NADH to fumarate electron transfer1713
nitrate reduction IX (dissimilatory)920
succinate to cytochrome bo oxidase electron transfer831
NADH to cytochrome bo oxidase electron transfer II526
D-lactate to cytochrome bo oxidase electron transfer527
glycerol-3-phosphate to cytochrome bo oxidase electron transfer529
proline to cytochrome bo oxidase electron transfer531
NADH to cytochrome bo oxidase electron transfer I1734
pyruvate to cytochrome bo oxidase electron transfer535
mixed acid fermentation3276
hydrogen to fumarate electron transfer816
glycerol-3-phosphate to fumarate electron transfer716

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1739766Inhibition of NDH-2 in wild type Mycobacterium smegmatis mc24517 inverted membrane vesicles assessed as reduction in oxygen consumption at 50 uM by NADH oxygen consumption assay2020European journal of medicinal chemistry, Sep-01, Volume: 201Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors.
AID732068Inhibition of Staphylococcus aureus AgrC12013Journal of medicinal chemistry, Feb-28, Volume: 56, Issue:4
Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective.
AID1739768Inhibition of NDH-2 in Mycobacterium tuberculosis H37Rv inverted membrane vesicles over expressing ndh gene assessed as reduction in oxygen consumption at 50 uM by NADH oxygen consumption assay2020European journal of medicinal chemistry, Sep-01, Volume: 201Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors.
AID1674266Cytotoxicity against human HeLa cells assessed as reduction in cell viability2020Journal of natural products, 07-24, Volume: 83, Issue:7
Isolation of 2-Alkyl-4-quinolones with Unusual Side Chains from a Chinese
AID1674265Antibacterial activity against Staphylococcus aureus2020Journal of natural products, 07-24, Volume: 83, Issue:7
Isolation of 2-Alkyl-4-quinolones with Unusual Side Chains from a Chinese
AID1674264Antibacterial activity against Staphylococcus epidermidis2020Journal of natural products, 07-24, Volume: 83, Issue:7
Isolation of 2-Alkyl-4-quinolones with Unusual Side Chains from a Chinese
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (119)

TimeframeStudies, This Drug (%)All Drugs %
pre-199043 (36.13)18.7374
1990's32 (26.89)18.2507
2000's22 (18.49)29.6817
2010's18 (15.13)24.3611
2020's4 (3.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.66 (24.57)
Research Supply Index4.79 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.68%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other117 (98.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]